A set of gene variants originating in Sub-Saharan West Africa may help explain why black women have worse breast cancer outcomes than white women, say researchers at Weill Cornell Medicine and NewYork-Presbyterian.
A molecule promoting blood vessel growth in bone can create an environment suitable for bone-building formation, representing a potential target for new drugs to treat osteoporosis.
Cornell and U.S Department of Agriculture researchers announced that they are releasing a nutritious new red rice cultivar that should appeal to people interested in alternative grains.
A major study led by Cornell researchers reveals for the first time that water troughs on farms are a pathway for the spread of toxic E. coli in cattle.
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccine.
Cross-campus gathering will focus on the biggest challenges facing the world, and help determine a theme on which the university will focus in the 2019-2020 academic year.
A signaling pathway in cells that regulates fat production could become a new target for cancer drugs, according to Weill Cornell Medicine researchers.
Ultrasmall Cornell dots armed with antibodies are another weapon in the fight against cancer, says Uli Wiesner, professor of materials science and engineering.